Black Rock Inc. Ocugen, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Ocugen, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 17,920,187 shares of OCGN stock, worth $17.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,920,187

Previous 3,799,240 371.68%

Holding current value

$17.7 Million

Previous $6.23 Million 345.84%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.18 - $1.98 $16.7 Million - $28 Million	14,120,947 Added 371.68%	17,920,187 $27.8 Million
Q1 2024 May 10, 2024	BUY	$0.5 - $1.83 $52,979 - $193,904	105,959 Added 2.87%	3,799,240 $6.23 Million
Q3 2023 Nov 13, 2023	SELL	$0.4 - $0.62 $85,653 - $132,762	-214,133 Reduced 5.48%	3,693,281 $1.48 Million
Q2 2023 Aug 11, 2023	SELL	$0.45 - $0.88 $5.04 Million - $9.86 Million	-11,204,506 Reduced 74.14%	3,907,414 $2.11 Million
Q1 2023 May 12, 2023	BUY	$0.82 - $1.33 $41,458 - $67,243	50,559 Added 0.34%	15,111,920 $12.8 Million
Q4 2022 Feb 13, 2023	BUY	$1.11 - $1.87 $1.68 Million - $2.82 Million	1,509,653 Added 11.14%	15,061,361 $19.6 Million
Q3 2022 Nov 14, 2022	SELL	$1.75 - $3.1 $395,143 - $699,967	-225,796 Reduced 1.64%	13,551,708 $24.1 Million
Q2 2022 Aug 12, 2022	BUY	$1.83 - $3.45 $2.95 Million - $5.57 Million	1,614,117 Added 13.27%	13,777,504 $31.3 Million
Q1 2022 May 12, 2022	SELL	$2.34 - $4.72 $1.8 Million - $3.62 Million	-767,744 Reduced 5.94%	12,163,387 $40.1 Million
Q4 2021 Feb 10, 2022	BUY	$4.38 - $15.67 $111,449 - $398,723	25,445 Added 0.2%	12,931,131 $58.8 Million
Q3 2021 Nov 09, 2021	SELL	$6.36 - $8.51 $211,342 - $282,787	-33,230 Reduced 0.26%	12,905,686 $92.7 Million
Q2 2021 Aug 11, 2021	BUY	$5.52 - $15.68 $71.4 Million - $203 Million	12,938,916 New	12,938,916 $104 Million

Others Institutions Holding OCGN

# of Institutions

108

Shares Held

66.5M

Call Options Held

516K

Put Options Held

272K

View Full List

About Ocugen, Inc.

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $214M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

More about OCGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account